Author

Jeanne Connor

Observed name: J. P. Connor

Institution: University of Alabama at Birmingham

Observed institutions: University of Wisconsin–Madison, University of Alabama at Birmingham

OpenAlex ID: A5006466176

GSK1120212, a MEK1/MEK2 Inhibitor, Demonstrates Acceptable Tolerability and Preliminary Activity In a Dose Rising Trial In Subjects with AML and Other Hematologic Malignancies

2010 · Gautam Borthakur, James M. Foran, et al. · Blood · 3

A Preliminary Report of a Phase I Study of Zevalin® Using a Modified Treatment Regimen for Relapsed or Refractory CD20+ B-Cell Follicular or Transformed Non-Hodgkin’s Lymphoma (NHL).

2005 · Andres Forero-Torres, Jatin Shah, et al. · Blood

Phase II trial of weekly docetaxel and carboplatin for recurrent ovarian and peritoneal cancer: Preliminary results including prevention of carboplatin hypersensitivity

2004 · D. M. Kushner, E. M. Hartenbach, et al. · Journal of Clinical Oncology

Works count: 3

Citation count: 3

H-index: 1

I10-index: